Volver a Agenda
Session 8: Innovations in Technology and Operational Excellence
Session Chair(s)
Jaclyn Bosco, PhD, MPH, FISPE
Vice President and Global Head of Epidemiology
IQVIA, United States
The expectations from regulators and other decision-making stakeholders are increasing for the use of real-world data to generate valid and robust evidence. Putting theory into practice has evolved using new technology and methods to improve our operational execution of real-world study protocols. This session will provide practical applications for the data journey from abstraction, linkage, programming and reporting to increase the quality of real- world evidence generation.
Learning Objective : - Understand the benefits and risks of human-only, AI-only, and human-in-the-loop AI-enabled data abstraction
Speaker(s)
AI-Enabled Data Abstraction: Benefits and Risks for Data Curation
Representative Invited
PicnicHealth, United States
Seeing Eye to Eye: Enhancing Inter-Team Communication for Reproducible Real World Evidence
Nuvan Rathnayaka
Target RWE, United States
Manager of Biostatistics
Supplementing the Identification of Clinical Endpoints through Tokenization of Clinical Trial Participants
Claudia A Salinas, PhD
Eli Lilly and Company, United States
Senior Director, GPS Pharmacoepidemiology
¿Tiene una cuenta?